InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Browse the full record of transactions filed by NUSSDORF GLENN H, Director. Officer active across 1 companies, notably Organogenesis Holdings Inc.. Cumulatively, 6 filings have been recorded. Total volume traded: €105m. The latest transaction was disclosed on 18 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€219,27925,000 shares@ €8.77120.033% mcap0.4% of flow
Class A Common Stock
SEC:0001062993-21-011406·
Ideal exit: 15 Aug 2022 (T+270)
€219,27925,000 shares@ €8.77120.033% mcap0.2% of flow
Class A Common Stock
SEC:0001062993-21-011406:0·
Ideal exit: 15 Aug 2022 (T+270)
€52m3,887,500 shares@ €13.45017.95% mcap99.6% of flow
Class A Common Stock
SEC:0001661181-21-000050·
€52m3,887,500 shares@ €13.45017.95% mcap49.8% of flow
Class A Common Stock
SEC:0001661181-21-000050:0·
023,855,148 shares0
Class A Common Stock
SEC:0001661181-21-000040·
023,855,148 shares0
Class A Common Stock
SEC:0001661181-21-000040:0·
6 of 6 declarations
About NUSSDORF GLENN H
Glenn H. Nussdorf is a Board Member at Organogenesis Holdings Inc. He plays a key role in the governance and strategy of the company. Nussdorf brings his experience in management and operations to the board. His commitment to efficiency and innovation is essential for the development of Organogenesis.
